Literature DB >> 12800067

GB virus type C/Hepatitis G virus.

Jack T Stapleton1.   

Abstract

After hepatitis G virus (HGV) and GB virus type C (GBV-C) were independently discovered, it was determined that they were two isolates of the same virus. The HGV/GBV-C genome sequence and organization are closely related to hepatitis C virus. Although HGV/GBV-C infection is common and frequently persists in humans, infection has not been found to be associated with any known disease state. Because this virus is not associated with acute or chronic hepatitis, most people refer to it as GBV-C. GBV-C appears to grow in lymphocytes and not in hepatocytes, and presumably this is why the virus does not cause liver disease. Recent studies suggest that GBV-C infection in HIV-positive people is associated with prolonged survival. In vitro coinfection of human lymphocytes with GBV-C and HIV lead to decreased HIV replication. Further understanding of the mechanism(s) responsible for this interaction with HIV may provide novel approaches for treating HIV and AIDS.

Entities:  

Mesh:

Year:  2003        PMID: 12800067     DOI: 10.1055/s-2003-39943

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  54 in total

Review 1.  GB virus type C: a beneficial infection?

Authors:  Jack T Stapleton; Carolyn F Williams; Jinhua Xiang
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

Review 2.  Tropism of human pegivirus (formerly known as GB virus C/hepatitis G virus) and host immunomodulation: insights into a highly successful viral infection.

Authors:  Ernest T Chivero; Jack T Stapleton
Journal:  J Gen Virol       Date:  2015-02-09       Impact factor: 3.891

Review 3.  History of the Discovery of Hepatitis A Virus.

Authors:  Stephen M Feinstone
Journal:  Cold Spring Harb Perspect Med       Date:  2019-05-01       Impact factor: 6.915

4.  Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication.

Authors:  Jinhua Xiang; James H McLinden; Thomas M Kaufman; Emma L Mohr; Nirjal Bhattarai; Qing Chang; Jack T Stapleton
Journal:  Virology       Date:  2012-05-16       Impact factor: 3.616

Review 5.  Role of GB virus C in modulating HIV disease.

Authors:  Carolynne Schwarze-Zander; Jason T Blackard; Juergen K Rockstroh
Journal:  Expert Rev Anti Infect Ther       Date:  2012-05       Impact factor: 5.091

6.  Human pegivirus (HPgV) infection in Ghanaians co-infected with human immunodeficiency virus (HIV) and hepatitis B virus (HBV).

Authors:  Kombo F N'Guessan; Ceejay Boyce; Awewura Kwara; Timothy N A Archampong; Margaret Lartey; Kwamena W Sagoe; Ernest Kenu; Adjoa Obo-Akwa; Jason T Blackard
Journal:  Virus Genes       Date:  2018-03-17       Impact factor: 2.332

7.  GB virus C envelope protein E2 inhibits TCR-induced IL-2 production and alters IL-2-signaling pathways.

Authors:  Nirjal Bhattarai; James H McLinden; Jinhua Xiang; Thomas M Kaufman; Jack T Stapleton
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

8.  Identification of GBV-D, a novel GB-like flavivirus from old world frugivorous bats (Pteropus giganteus) in Bangladesh.

Authors:  Jonathan H Epstein; Phenix-Lan Quan; Thomas Briese; Craig Street; Omar Jabado; Sean Conlan; Shahneaz Ali Khan; Dawn Verdugo; M Jahangir Hossain; Stephen K Hutchison; Michael Egholm; Stephen P Luby; Peter Daszak; W Ian Lipkin
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

9.  Viruses within the Flaviviridae decrease CD4 expression and inhibit HIV replication in human CD4+ cells.

Authors:  Jinhua Xiang; James H McLinden; Robert A Rydze; Qing Chang; Thomas M Kaufman; Donna Klinzman; Jack T Stapleton
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

10.  Chimpanzee GB virus C and GB virus A E2 envelope glycoproteins contain a peptide motif that inhibits human immunodeficiency virus type 1 replication in human CD4⁺ T-cells.

Authors:  James H McLinden; Jack T Stapleton; Donna Klinzman; Krishna K Murthy; Qing Chang; Thomas M Kaufman; Nirjal Bhattarai; Jinhua Xiang
Journal:  J Gen Virol       Date:  2013-01-03       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.